Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Starekova, D. Bluemke, W. Bradham, L. Eckhardt, T. Grist, J. Kusmirek, Christopher Purtell, M. Schiebler, S. Reeder (2021)
Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging.JAMA cardiology
Vago (2020)
Cardiac magnetic resonance findings in patients recovered from COVID-19: initial experiences in elite athletes.JACC Cardiovasc Imaging
Jonathan Kim, B. Levine, D. Phelan, M. Emery, M. Martinez, Eugene Chung, P. Thompson, A. Baggish (2020)
Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play.JAMA cardiology
Big TenCOVID-19CardiacRegistryInvestigators
Daniels (2021)
Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the Big Ten COVID-19 Cardiac Registry.JAMA Cardiol
K. Harris, S. Mackey-Bojack, Mosi Bennett, Darlington Nwaudo, E. Duncanson, B. Maron (2020)
Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes.The American journal of cardiology
C. Eichhorn, L. Bière, F. Schnell, C. Schmied, M. Wilhelm, R. Kwong, C. Gräni (2020)
Myocarditis in Athletes Is a Challenge: Diagnosis, Risk Stratification, and Uncertainties.JACC. Cardiovascular imaging
Matthew Martinez, A. Tucker, O. Bloom, Gary Green, J. Difiori, G. Solomon, D. Phelan, Jonathan Kim, W. Meeuwisse, A. Sills, D. Rowe, I. Bogoch, Paul Smith, A. Baggish, M. Putukian, D. Engel (2021)
Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening.JAMA cardiology
D. Nieman (2021)
Faculty Opinions recommendation of Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry.Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
J. Udelson, Michael Curtis, E. Rowin (2020)
Return to Play for Athletes After Coronavirus Disease 2019 Infection-Making High-Stakes Recommendations as Data Evolve.JAMA cardiology
Ł. Małek, M. Marczak, B. Miłosz-Wieczorek, M. Konopka, W. Braksator, W. Drygas, J. Krzywański (2021)
Cardiac involvement in consecutive elite athletes recovered from Covid‐19: A magnetic resonance studyJournal of Magnetic Resonance Imaging, 53
Benjamin Hendrickson, Ryan Stephens, James Chang, Jacob Amburn, Lindsey Pierotti, Jessica Johnson, John Hyden, J. Johnson, R. Philip (2021)
Cardiovascular Evaluation After COVID-19 in 137 Collegiate Athletes: Results of an Algorithm-Guided Screening.Circulation, 143 19
H. Vágó, L. Szabó, Z. Dohy, B. Merkely (2020)
Cardiac Magnetic Resonance Findings in Patients Recovered From COVID-19Jacc. Cardiovascular Imaging, 14
Jonathan Kim (2021)
Screening Athletes for Myocarditis With Cardiac Magnetic Resonance Imaging After COVID-19 Infection-Lessons From an English Philosopher.JAMA cardiology
D. Clark, Amar Parikh, J. Dendy, A. Diamond, Kristen George-Durrett, F. Fish, J. Slaughter, Warne Fitch, Sean Hughes, J. Soslow (2020)
COVID-19 Myocardial Pathology Evaluation in Athletes With Cardiac Magnetic Resonance (COMPETE CMR)Circulation, 143
S. Rajpal, M. Tong, J. Borchers, K. Zareba, T. Obarski, O. Simonetti, C. Daniels (2020)
Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection.JAMA cardiology
Nathaniel Moulson, B. Petek, J. Drezner, K. Harmon, S. Kliethermes, M. Patel, A. Baggish (2021)
SARS-CoV-2 Cardiac Involvement in Young Competitive AthletesCirculation, 144
A. Baggish, M. Ackerman, R. Lampert (2017)
Competitive Sport Participation Among Athletes With Heart Disease: A Call for a Paradigm Shift in Decision Making.Circulation, 136 17
Opinion EDITORIAL The Fog Begins to Clear James E. Udelson, MD; Ethan J. Rowin, MD; Barry J. Maron, MD In October 2020, Kim and colleagues, representing the Ameri- normal ECG, echocardiography, and troponin test results, who can College of Cardiology’s Sports and Exercise Council, would not have been identified without CMR imaging. While some of the prior studies involving smaller patient cohorts had published recommendations for the evaluation of athletes 2,4,5 who had tested positive for also reported all athletes undergoing CMR imaging, it was COVID-19 to ensure safe re- unclear what selection may have taken place before CMR Related article page 1078 turn to play. The group rec- imaging referral. ommended a tiered approach This mandated comprehensive testing in a large group of based on the presence of symptoms, followed by electrocar- collegiate athletes provides the novel opportunity not previ- diography (ECG), injury biomarkers, and echocardiography. ously available in large athlete cohorts (to our knowledge) to Abnormalities were then to be further characterized by the se- construct the data in their Figure 2, which succinctly sum- lective use of cardiac magnetic resonance (CMR) imaging. The marizes what would have been detected and missed by vari- recommendations were based
JAMA Cardiology – American Medical Association
Published: Sep 27, 2021
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.